Dependent on the underlying defect, B cell activation and development might be compromised at different levels enabling B cells of certain patients with CVID to mount an IgM antibody response, while B cells of other CVID patients with more severe defects cannot produce any antibodies at all (25). This evidence concerns the gene CD40LG and common variable immunodeficiency.